| Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. Gonin J., Larousserie F., Bastard C., Picquenot J.M., Couturier J., Radford-Weiss I., Dietrich C., Brousse N., Vacher-Lavenu M.C., Devergne O.
PLoS ONE 6:e24617-e24617(2011) · Mapped (1) |
| Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. Moreira-Teixeira L., Resende M., Coffre M., Devergne O., Herbeuval J.P., Hermine O., Schneider E., Rogge L., Ruemmele F.M., Dy M. et al.
J. Immunol. 186:5758-5765(2011) · Mapped (3) |
| Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Kempe S., Heinz P., Kokai E., Devergne O., Marx N., Wirth T.
Am. J. Pathol. 175:440-447(2009) · Mapped (1) |
| Drosophila RalA is essential for the maintenance of Jak/Stat signalling in ovarian follicles. Ghiglione C., Devergne O., Cerezo D., Noselli S.
EMBO Rep. 9:676-682(2008) · Mapped (6) |
| The endocytic control of JAK/STAT signalling in Drosophila. Devergne O., Ghiglione C., Noselli S.
J. Cell. Sci. 120:3457-3464(2007) · Mapped (15) |
| Differential effects of IL-27 on human B cell subsets. Larousserie F., Charlot P., Bardel E., Froger J., Kastelein R.A., Devergne O.
J. Immunol. 176:5890-5897(2006) · Mapped (1) |
| Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Larousserie F., Bardel E., Pflanz S., Arnulf B., Lome-Maldonado C., Hermine O., Bregeaud L., Perennec M., Brousse N., Kastelein R. et al.
Am. J. Pathol. 166:1217-1228(2005) · Mapped (1) |
| Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. Gehlert T., Devergne O., Niedobitek G.
J. Med. Virol. 73:432-438(2004) · Mapped (1) |
| Expression of IL-27 in human Th1-associated granulomatous diseases. Larousserie F., Pflanz S., Coulomb-L'Hermine A., Brousse N., Kastelein R., Devergne O.
J. Pathol. 202:164-171(2004) |
| The Drosophila cytokine receptor Domeless controls border cell migration and epithelial polarization during oogenesis. Ghiglione C., Devergne O., Georgenthum E., Carballes F., Medioni C., Cerezo D., Noselli S.
Development 129:5437-5447(2002) · UniProtKB (1) · Mapped (21) |
| TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. Hatzoglou A., Roussel J., Bourgeade M.-F., Rogier E., Madry C., Inoue J., Devergne O., Tsapis A.
J. Immunol. 165:1322-1330(2000) · UniProtKB (3) |
| Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Devergne O., Birkenbach M., Kieff E.
Proc. Natl. Acad. Sci. U.S.A. 94:12041-12046(1997) |
| Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. Franken M., Devergne O., Rosenzweig M., Annis B., Kieff E., Wang F.
J. Virol. 70:7819-7826(1996) · UniProtKB (81) |
| Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., Mosialos G.
Proc. Natl. Acad. Sci. U.S.A. 93:11085-11090(1996) · UniProtKB (1) |
| A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., Kieff E., Birkenbach M.
J. Virol. 70:1143-1153(1996) · UniProtKB (2) |
